Cim, LLC Biogen Inc. Transaction History

Cim, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $5.47 Million - $8.24 Million	-23,165 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$264.77 - $305.71 $69,369 - $80,096	262 Added 1.14%	23,165 $7.62 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $5.9 Million - $7.82 Million	-22,821 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $85,763 - $108,791	-319 Reduced 1.38%	22,821 $7.22 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $11,663 - $16,115	-53 Reduced 0.23%	23,140 $6.87 Million

Q3 2019 Oct 15, 2019	BUY	$217.44 - $243.88 $2.09 Million - $2.35 Million	9,631 Added 71.01%	23,193 $5.4 Million
Q2 2019 Jul 22, 2019	SELL	$219.29 - $241.72 $3.18 Million - $3.5 Million	-14,486 Reduced 51.65%	13,562 $3.17 Million
Q1 2019 May 06, 2019	BUY	$216.71 - $338.96 $127,208 - $198,969	587 Added 2.14%	28,048 $6.63 Million
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $104,437 - $132,281	375 Added 1.38%	27,461 $8.26 Million
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $963,299 - $1.26 Million	-3,282 Reduced 10.81%	27,086 $9.57 Million
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $645,602 - $769,423	2,507 Added 9.0%	30,368 $8.81 Million
Q1 2018 Apr 05, 2018	BUY	$260.13 - $367.91 $74,397 - $105,222	286 Added 1.04%	27,861 $7.63 Million
Q4 2017 Jan 23, 2018	BUY	$307.64 - $344.58 $25,226 - $28,255	82 Added 0.3%	27,575 $8.79 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $6,185 - $7,253	22 Added 0.08%	27,493 $8.61 Million
Q2 2017 Aug 09, 2017	BUY	N/A	27,471	27,471 $7.46 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.